Form 4 PFIZER INC For: Apr 24 Filed by: LITTMAN DAN R.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
JPMorgan Reiterates Neutral Rating on Pfizer (PFE)
April 29, 2025 4:14 PM EDTJPMorgan analyst Chris Schott reiterated a Neutral rating and $30.00 price target on Pfizer (NYSE: PFE).
The analyst comments "Exiting PFEs 1Q results and our follow up with the company, we want to provide our key takeaways. On the qtr, PFE's sales came in below expectations (which is not surprising as... More
